SGMOQ 8-K 2026-07-20

SANGAMO THERAPEUTICS, INC (SGMOQ) 8-K dated 2026-07-20 — accession 0001193125-26-309012.

SANGAMO THERAPEUTICS, INC (SGMOQ) common stock.

SANGAMO THERAPEUTICS, INC filed a 8-K on 2026-07-20. Accession 0001193125-26-309012.

This 8-K covers: Bankruptcy or receivership (Item 1.03), Listing notice (Item 3.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported SGMOQ revenue for 2025-12-31 was $39.6M. Net income was -$122.9M. Revenue was down 31.6% from 2024-12-31 to 2025-12-31.

Not investment advice. The SGMOQ SEC hub lists recent forms. The stock page is the research view.